Revenue of $9.1 million, Adjusted EBITDA of $2.9 million, Adjusted EBITDA Margin of 32%. Generated positive EBITDA of $1.6 million. Expanded retail footprint through the acquisition of Jackson, Ohio dispensary and reported solid performance during first quarter under Vext ownership. Previously announced acquisition of vertically integrated Ohio operations on track to close towards the end of Q3 2023 and ..read more

MILAN, Italy, May 25, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its medical cannabis division, Tilray Medical and FL Group, the Company’s subsidiary in Italy, have received authorization from Italy’s Ministry of Health to distribute three new medical ..read more

LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today reported its financial results for the fourth quarter and year ended December 31, 2022, on www.sedar.com. Financial Highlights for FY 2022 (all comparisons are for the year ended December 31 unless otherwise indicated): Annual revenue was $89.5 million, down 10.8% from $100.3 ..read more

Vancouver, British Columbia--(Newsfile Corp. - May 29, 2023) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) ("CENTR" or the "Company"), a leading manufacturer of better-for-you beverages, is pleased to announce it has experienced significant chain store adoption in key markets for its recently launched CENTR Enhanced functional beverage. CENTR Enhanced+ Caffeine CENTR Enhanced, a better-for-you ..read more

Refinances a meaningful portion of our debt due in June 2024, extending maturity to 2027 and locking in lower fixed interest rate of 5.20%; Strengthens balance sheet with additional cash proceeds of $15 million or $37 million if over-allotment is exercised in full, to be used for strategic acquisitions and to pay down debt; Brings the Company’s current cash, cash equivalents and marketable securities on hand ..read more

TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the execution of the definitive Asset Purchase Agreement (“Agreement”) between Shoppers Drug Mart®  (“Shoppers”) and Avicanna for ..read more

As part of the Company's corporate restructuring plan, Mr. Yaki Baranes will facilitate identifying new business opportunities TEL AVIV, Israel, May 30, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that as part of its ..read more

TOCANCIPÁ, Colombia, May 30, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a global medicinal cannabis company, announced today the arrival of the company’s first shipment of medical cannabis extracts from Colombia to Switzerland-based partner, Astrasana Holding AG (“Astrasana”). This marks the first commercial shipment for Clever Leaves to Switzerland, where ..read more

Canopy Growth to control all distribution, marketing, and sales of industry leading Wana branded products in Canada, further uniting the Company's North American house of brands Indiva to manufacture Wana for Canopy in Canada under exclusivity ensuring continuity of quality product supply Canopy to acquire 19.99% interest in Indiva as part of the transactions SMITHS FALLS, ON and LONDON, ON, May 30, 2023 ..read more

Total revenue of $15.1 million in Q1 2023 represents a 24% sequential increase over Q4 2022. Net Revenue in medical accounted for $6.0 million, a 61% sequential increase over Q4 2022. Color Cannabis captured a 5.3% national market share in the pre-roll segment.1 Management will host a conference call on May 30, 2023, at 10 a.m. Eastern Time. TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Entourage Health ..read more